0M0F Stock Overview
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 1/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Tandem Diabetes Care, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$34.67 |
52 Week High | US$38.27 |
52 Week Low | US$13.89 |
Beta | 1.13 |
1 Month Change | 14.69% |
3 Month Change | 52.13% |
1 Year Change | -7.55% |
3 Year Change | -60.55% |
5 Year Change | -45.90% |
Change since IPO | -8.30% |
Recent News & Updates
Recent updates
Shareholder Returns
0M0F | GB Medical Equipment | GB Market | |
---|---|---|---|
7D | 10.1% | 2.0% | 2.7% |
1Y | -7.5% | -8.5% | 0.3% |
Return vs Industry: 0M0F exceeded the UK Medical Equipment industry which returned -8.5% over the past year.
Return vs Market: 0M0F underperformed the UK Market which returned 0.3% over the past year.
Price Volatility
0M0F volatility | |
---|---|
0M0F Average Weekly Movement | 10.7% |
Medical Equipment Industry Average Movement | 8.1% |
Market Average Movement | 4.9% |
10% most volatile stocks in GB Market | 11.3% |
10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: 0M0F's share price has been volatile over the past 3 months.
Volatility Over Time: 0M0F's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2006 | 2,400 | John Sheridan | www.tandemdiabetes.com |
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company’s flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user’s body.
Tandem Diabetes Care, Inc. Fundamentals Summary
0M0F fundamental statistics | |
---|---|
Market cap | US$2.26b |
Earnings (TTM) | -US$222.61m |
Revenue (TTM) | US$747.72m |
3.0x
P/S Ratio-10.1x
P/E RatioIs 0M0F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
0M0F income statement (TTM) | |
---|---|
Revenue | US$747.72m |
Cost of Revenue | US$380.03m |
Gross Profit | US$367.69m |
Other Expenses | US$590.30m |
Earnings | -US$222.61m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 02, 2024
Earnings per share (EPS) | -3.45 |
Gross Margin | 49.18% |
Net Profit Margin | -29.77% |
Debt/Equity Ratio | 92.4% |
How did 0M0F perform over the long term?
See historical performance and comparison